Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma.

@article{Decaens2005ImpactOP,
  title={Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma.},
  author={Thomas Decaens and Françoise Roudot-Thoraval and Solange Bresson-Hadni and Carole Meyer and Jean Gugenheim and François Durand and P P Bernard and Olivier Boillot and Karim Boudj{\'e}ma and Yvon Calmus and Jean Hardwigsen and Christian Ducerf and Georges Philippe Pageaux and S{\'e}bastien Dharancy and Olivier Chazouilleres and Daniel Dhumeaux and Daniel Cherqui and Christophe Duvoux},
  journal={Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society},
  year={2005},
  volume={11 7},
  pages={767-75}
}
The actual impact of transarterial chemoembolization before liver transplantation (LT) for hepatocellular carcinoma (HCC) on patient survival and HCC recurrence is not known. Between 1985 and 1998, 479 patients with HCC in 14 French centers were evaluated for LT. Among these 479 patients, this case-control study included 100 patients who received transarterial chemoembolization before LT (TACE group) and 100 control patients who did not receive chemoembolization (no-TACE group). Patients and… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 65 extracted citations

Similar Papers

Loading similar papers…